Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-04-25

Clinical Trial Update: Magnesium Supplements In The Treatment Of Pseudoxanthoma Elasticum (PXE) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating magnesium supplements for treating Pseudoxanthoma Elasticum has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Mark Lebwohl | Conditions: Pseudoxanthoma Elasticum | Phase 2 | Status: COMPLETED | Results posted: 2019-04-25